samedan logo

home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market 

For further information please contact:

Simon Caplan

Will Brown

We're also on Twitter! Follow us @PMPSmag   


Click here to view the digital version of PMPS




Click here to view the digital version



Featured in this issue
Supply Chain
Supply Chain

Procurement in a Pandemic – Building Resilience into the Pharma Supply Chain for 2021

Collaboration has been integral amid COVID-19, and pharma working together may well hold the key to mitigating and managing risk for future pandemics and logistical turbulence.
Tabletting and Capsule Technologies
Tabletting and Capsule Technologies

Capsule Trends in the Nutraceutical Markets

Vegan and non-GMO choices are helping to accelerate the development of the nutraceuticals market, which has already seen increased focus in recent years. What other trends exist in the capsuling world that are aiding nutraceuticals?
Inhalation Technology Supplement

How the EU and US Are Aligning Guidance for Inhalation Products

The ever-evolving worldwide regulations for all medical devices and drugs have forced two major bodies to combine their expertise to ensure quality, purity, and safety.


Published quarterly in
February, May,
August, and November


Industry Events

A Magic Triangle: Practical insights into lactose-based DPI formulations

30 June 2021, Online webinar

Three leading companies with complementary areas of expertise have joined forces to conduct a unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate. Their findings will give generic players a head start in the development process so that they can tap into this rapidly growing market. Lactose specialist DFE Pharma, powder processing technology manufacturer Hosokawa Micron and machine-building expert Harro Hoefliger will be presenting the key insights from their research to interested parties during a joint webinar on the 30th of June.
More info >>

News and Press Releases

Oncology: Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532

Lyon, France, May 18, 2021 – Tollys, a biopharmaceutical company responsible for developing TL-532, the first anti-cancer immunotherapy based on a synthetic toll-like receptor 3 (TLR3) specific agonist, today announces that it has been awarded the ‘Best-in-Class Therapeutic Innovation’ prize by the MATWIN international board.
More info >>

White Papers

Protein Therapeutics

Reading Scientific Services Ltd (RSSL)

More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement